Anaptysbio (ANAB) EBT Margin (2016 - 2026)

Anaptysbio (ANAB) reported EBT Margin of 206.78% for Q1 2026, down 6532.0% on a YoY basis from 3.21% in Q1 2025, and down 347.09% quarter-over-quarter from 83.68% in Q4 2025.

Anaptysbio (ANAB) EBT Margin (2016 - 2026) Analysis & Trends

Anaptysbio has reported EBT Margin for 11 years, with the latest figure at 206.78% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 6532.0% year-over-year to 206.78%; the trailing twelve-month figure through Mar 2026 stood at 7.85% (up 17086.0% YoY), and the FY2024 full-year result was 159.25%, down 15900.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 206.78%, down from 83.68% in the prior quarter.
  • The five-year high for EBT Margin was 1347.75% in Q4 2023, with the low at 3237.84% in Q1 2022.
  • Historically, EBT Margin has averaged 798.67% across 5 years, with a median of 425.22% in 2024.
  • The largest YoY upside for EBT Margin was 263239 bps in 2022 against a maximum downside of 305618 bps in 2022.
  • Anaptysbio's EBT Margin stood at 442.68% in 2022, then jumped by 404 bps to 1347.75% in 2023, then tumbled by 107 bps to 87.72% in 2024, then soared by 195 bps to 83.68% in 2025, then plunged by 347 bps to 206.78% in 2026.
  • The last three EBT Margin figures came in at 206.78% (Q1 2026), 83.68% (Q4 2025), and 30.23% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Anaptysbio 1.66 Bn 1.38 Bn - -206.78%

Historic Data

Download Data
DateValue
Mar 31, 2026 -206.78%
Dec 31, 2025 83.68%
Sep 30, 2025 30.23%
Jun 30, 2025 -173.34%
Mar 31, 2025 -141.46%
Dec 31, 2024 -87.72%
Sep 30, 2024 -219.01%
Jun 30, 2024 -425.22%
Mar 31, 2024 -612.01%
Dec 31, 2023 1,347.75%
Sep 30, 2023 -1,124.41%
Jun 30, 2023 -1,151.59%
Mar 31, 2023 -2,905.02%
Dec 31, 2022 -442.68%
Sep 30, 2022 -2,116.86%
Jun 30, 2022 -2,195.07%
Mar 31, 2022 -3,237.84%
Dec 31, 2021 -3,075.07%
Sep 30, 2021 -33.50%
Jun 30, 2021 -2.15%